Health Care Equipment & Services

Boston Scientific’s revised target price shows a cautious outlook amid slowing growth, but its strategic acquisitions in a consolidating medical‑device market signal hidden upside and resilience.

Siemens Healthineers leads the Fourth China International Supply Chain Expo, showcasing AI‑powered diagnostics, local manufacturing, and market‑stable tech that boosts global healthcare innovation.

UnitedHealth Group’s rising dividend, strong Medicare‑Advantage margins and data‑analytics moat make it a top defensive income stock for savvy investors.

Fresenius Medical Care faces short‑term revenue pressure after EMA recommends revoking TAVNEOS, yet strong margins, cash reserves and a diverse renal portfolio offer resilience amid regulatory uncertainty.

Pro Medicus invests up to A$20 million in Echo IQ, merging capital with U.S. reseller power to launch AI‑powered EchoSolv cardiac diagnostics after FDA clearance.

Insider trading at Becton, Dickinson (BDX) shows routine, plan‑based sales with no market impact, yet offers insight into RSU timing, governance, and digital health strategy.

Philips faces new analyst scrutiny as tariff shifts and tougher regulatory rules threaten its respiratory tech profits, urging investors to weigh supply‑chain risks and pricing power.

McKesson’s pivot to digital health—leveraging its pharma logistics with AI‑powered RPM, CDSS, and data‑broker services—offers a 33% digital revenue boost amid rising regulatory and competitive challenges.

Insider trading at Cencora (COR): Director Lauren M. Tyler buys hundreds of shares, signaling confidence and offering investors a fresh view on governance and future prospects.

Discover how HCA Healthcare’s decade‑long stock outperformed the market—uncover the drivers, risks, and future prospects for long‑term investors.